Authors: Davis, AM Inturrisi, CE

Citation: Am. Davis et Ce. Inturrisi, Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist, BRAIN RES, 894(1), 2001, pp. 150-153

Authors: Portenoy, RK Caraceni, A Cherny, NI Goldblum, R Ingham, J Inturrisi, CE Johnson, JH Lapin, J Tiseo, PJ Kreek, MJ

Citation: Rk. Portenoy et al., Dynorphin A(1-13) analgesia in opioid-treated patients with chronic pain -A controlled pilot study, CLIN DRUG I, 17(1), 1999, pp. 33-42

Authors: Shimoyama, M Shimoyama, N Gorman, AL Elliott, KJ Inturrisi, CE

Citation: M. Shimoyama et al., Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine, PAIN, 81(1-2), 1999, pp. 85-93

Authors: Davis, AM Inturrisi, CE

Citation: Am. Davis et Ce. Inturrisi, d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia, J PHARM EXP, 289(2), 1999, pp. 1048-1053

Authors: Collins, JJ Dunkel, IJ Gupta, SK Inturrisi, CE Lapin, J Palmer, LN Weinstein, SM Portenoy, RK

Citation: Jj. Collins et al., Transdermal fentanyl in children with cancer pain: Feasibility, tolerability, and pharmacokinetic correlates, J PEDIAT, 134(3), 1999, pp. 319-323

Authors: Kest, B Jenab, S Brodsky, M Sadowski, B Belknap, JK Mogil, JS Inturrisi, CE

Citation: B. Kest et al., Mu and delta opioid receptor analgesia, binding density, and mRNA levels in mice selectively bred for high and low analgesia, BRAIN RES, 816(2), 1999, pp. 381-389